Type 2 diabetes is a condition where the body doesn’t make enough of the hormone insulin or use it effectively. Here, MDs ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

With 5.6 million people living with diabetes in the UK, practice managers can make a significant impact by fostering ...

Internal medicine and rheumatology specialist Siobhan Deshauer, MD, goes over the visual physical signs that a patient might ...